Reference is made to the ongoing rights issue of 4,090,909 new shares (the
"Offer Shares") at a subscription price of NOK 11.00 per share in Observe
Medical ASA (the "Company") as announced in the Company's stock exchange
announcement on 19 June 2020 (the "Rights Issue").

Primary insider, Kathrine Gamborg Andreassen, a member of the Company's board of
directors, has today, on 30 June 2020, through her wholly-owned company Soleglad
Invest AS, sold 144,428 subscription rights to subscribe for Offer Shares in the
Rights Issue at a price of NOK 1.60 per subscription right.

Following the sale of the subscription rights, Kathrine Gamborg Andreassen, with
related parties, holds no subscription rights to subscribe for Offer Shares in
the Rights Issue and a total of 541,668 shares and 125,000 options in the
Company.

This information is subject to disclosure requirements pursuant to section 4-2
of the Norwegian Securities Trading Act.